Tudor Investment Corp’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-40,112
Closed -$2.04M 2102
2025
Q1
$2.04M Sell
40,112
-7,039
-15% -$359K 0.01% 807
2024
Q4
$2.13M Buy
47,151
+8,505
+22% +$384K 0.01% 738
2024
Q3
$1.43M Sell
38,646
-14,515
-27% -$539K 0.01% 897
2024
Q2
$1.63M Buy
53,161
+24,687
+87% +$755K 0.01% 801
2024
Q1
$828K Sell
28,474
-21,081
-43% -$613K 0.01% 950
2023
Q4
$1.37M Buy
+49,555
New +$1.37M 0.01% 840
2022
Q4
Sell
-8,626
Closed -$433K 1890
2022
Q3
$433K Sell
8,626
-8,257
-49% -$414K 0.01% 1154
2022
Q2
$676K Buy
16,883
+3,041
+22% +$122K 0.02% 964
2022
Q1
$516K Buy
13,842
+3,669
+36% +$137K 0.01% 1099
2021
Q4
$405K Sell
10,173
-104,734
-91% -$4.17M 0.01% 1235
2021
Q3
$4.28M Buy
114,907
+24,666
+27% +$918K 0.07% 270
2021
Q2
$3.81M Buy
90,241
+53,087
+143% +$2.24M 0.07% 302
2021
Q1
$1.76M Buy
37,154
+17,697
+91% +$838K 0.04% 569
2020
Q4
$1.19M Buy
+19,457
New +$1.19M 0.03% 622
2019
Q4
Sell
-8,037
Closed -$272K 1333
2019
Q3
$272K Buy
+8,037
New +$272K 0.01% 873
2019
Q2
Sell
-10,612
Closed -$399K 1282
2019
Q1
$399K Sell
10,612
-8,738
-45% -$329K 0.02% 774
2018
Q4
$664K Buy
19,350
+8,352
+76% +$287K 0.01% 497
2018
Q3
$517K Buy
+10,998
New +$517K 0.01% 663
2018
Q1
Sell
-27,031
Closed -$451K 1177
2017
Q4
$451K Buy
27,031
+7,761
+40% +$129K 0.01% 646
2017
Q3
$386K Buy
+19,270
New +$386K 0.01% 721
2017
Q2
Sell
-41,670
Closed -$410K 1297
2017
Q1
$410K Buy
+41,670
New +$410K 0.01% 798
2016
Q3
Sell
-10,500
Closed -$74K 1570
2016
Q2
$74K Sell
10,500
-72,927
-87% -$514K ﹤0.01% 1362
2016
Q1
$537K Buy
+83,427
New +$537K 0.01% 702
2015
Q4
Sell
-9,400
Closed -$251K 1645
2015
Q3
$251K Sell
9,400
-400
-4% -$10.7K 0.01% 1151
2015
Q2
$472K Buy
9,800
+6,486
+196% +$312K 0.01% 776
2015
Q1
$202K Sell
3,314
-5,563
-63% -$339K 0.01% 1288
2014
Q4
$460K Buy
8,877
+4,166
+88% +$216K 0.02% 767
2014
Q3
$207K Buy
+4,711
New +$207K 0.01% 1169